Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Active not recruiting × Seizures × Clear all

Phase

Phase 4 1 Phase 3 1

Status

Completed 3 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 6 Papillomavirus Infections 6 Neoplasms 6 Breast Neoplasms 6 Colorectal Neoplasms 4 Tuberous Sclerosis 3 Hematologic Neoplasms 3 Stomach Neoplasms 2 Smoking Cessation 2 Rectal Neoplasms 2 Polycystic Ovary Syndrome 2 Pancreatic Neoplasms 2 Multiple Myeloma 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Graft vs Host Disease 2 Glioma 2 Glioblastoma 2 Dupuytren Contracture 2 Diabetes Mellitus 2 Dementia 2 Cardiovascular Diseases 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Bronchiolitis Obliterans Syndrome 2 Wrist Fractures 1 Vaccine-Preventable Diseases 1 Tumor Lysis Syndrome 1 Tobacco Use Cessation 1 Thyroid Neoplasms 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05864846 2026-03-12

EpiCom

Jazz Pharmaceuticals

Phase 4 Active not recruiting

Behavior, Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡